Alyssa Gallipani

ORCID: 0000-0001-6613-4376
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Hepatitis C virus research
  • Health Sciences Research and Education
  • Pharmaceutical Practices and Patient Outcomes
  • Innovations in Medical Education
  • Parkinson's Disease and Spinal Disorders
  • Hepatitis B Virus Studies
  • Pharmacogenetics and Drug Metabolism
  • BRCA gene mutations in cancer
  • Anesthesia and Pain Management
  • Pain Management and Opioid Use
  • Viral-associated cancers and disorders
  • Ethics in Clinical Research
  • HIV/AIDS drug development and treatment
  • Pathogenesis and Treatment of Hiccups
  • Opioid Use Disorder Treatment
  • Schizophrenia research and treatment

Fairleigh Dickinson University
2018-2023

Eaton (United States)
2021

Saint Barnabas Medical Center
2019

Monmouth Medical Center
2017

Brooklyn Hospital Center
2016

The use of adjunct, non-opioid agents is integral for pain control following total hip and knee arthroplasty. Literature comparing safety profiles intravenous acetaminophen versus opioids lacking.To determine whether there a difference in frequency type adverse effects between acetaminophen-treated non-intravenous patients. Primary endpoints included any effect noted the electronic medical record post-surgically. Secondary changes laboratory values, vital signs, scores.This retrospective,...

10.1177/2050312117699146 article EN cc-by-nc SAGE Open Medicine 2017-01-01

Few qualitative studies have explored the attitude of prescribers towards implementation pharmacogenomic testing in family medicine (FM) setting, and none among FM residents. The purpose this study was to describe level engagement interest education an clinic within a residency program.A utilizing semistructured interviews conducted at Brooklyn Hospital Center (TBHC). Voluntary included residents attendings. No were excluded. Prior interview, informational sheets about pharmacogenomics...

10.22454/primer.2018.493524 article EN PRiMER 2018-10-11

To outline an approach to help students achieve Entrustable Professional Activities (EPAs) entrustment during a sequence of Advanced Pharmacy Practice Experiences (APPEs) by implementing longitudinal monitoring and individualized intervention remediation strategies.

10.1016/j.ajpe.2024.100755 article EN American Journal of Pharmaceutical Education 2024-08-03

This report describes a case of concomitant treatment advanced diffuse large B-cell lymphoma with chemoimmunotherapy along direct-acting antivirals for hepatitis C virus in patient coinfected HIV. The tolerated gemcitabine, dexamethasone, cisplatin, and rituximab achieved sustained virologic response after ledipasvir/sofosbuvir.

10.1177/2325958218822062 article EN cc-by-nc Journal of the International Association of Providers of AIDS Care (JIAPAC) 2019-01-01

To describe how continuous performance monitoring and early intervention individualized in-course remediation strategies implemented during the Advanced Pharmacy Practice Experience (APPE) year can improve students' achievement of minimum entrustment level for each Entrustable Professional Activity (EPA) decreasing need end remediation.

10.1016/j.ajpe.2023.100243 article EN American Journal of Pharmaceutical Education 2023-08-01

Abstract Background Liver cancer rates are rising in the US, viral hepatitis accounting for more than 65% of cases. Yet half infections remain undiagnosed. In response to rise HCV due opioid epidemic, Centers Disease Control and Prevention began recommending a one-time test all adults 2020. Screening, linkage care (LTC) access curative therapy must be scaled up reach WHO goal eliminating by 2030. Methods 2018, automated screening utilizing electronic medical record protocols emergency...

10.1093/ofid/ofab466.1103 article EN cc-by Open Forum Infectious Diseases 2021-11-01
Coming Soon ...